31.01.2023 - 02.02.2023Omni Parker House, 60 School Street, 02108 Boston, Massachusetts, USA
Time: 9:00 am - 4:30 pm
Kongressthemen As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.